HUNTSMAN CORP (HUN) Stock Fundamental Analysis
USA - NYSE:HUN - US4470111075 - Common Stock
8.75 USD
+0.59 (+7.23%)
8.75 USD
0 (0%)
We assign a fundamental rating of 3 out of 10 to HUN. HUN was compared to 83 industry peers in the Chemicals industry. HUN may be in some trouble as it scores bad on both profitability and health. HUN is valued expensive and it does not seem to be growing. HUN also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
HUN had negative earnings in the past year.
In the past year HUN had a positive cash flow from operations.
HUN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years HUN had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -4.72%, HUN is not doing good in the industry: 71.08% of the companies in the same industry are doing better.
HUN has a Return On Equity of -12.03%. This is in the lower half of the industry: HUN underperforms 69.88% of its industry peers.
HUN has a worse Return On Invested Capital (0.72%) than 77.11% of its industry peers.
HUN had an Average Return On Invested Capital over the past 3 years of 3.85%. This is below the industry average of 6.30%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.72% | ||
| ROE | -12.03% | ||
| ROIC | 0.72% |
ROA(3y)1.44%
ROA(5y)5.47%
ROE(3y)3.16%
ROE(5y)12.59%
ROIC(3y)3.85%
ROIC(5y)4.46%
1.3 Margins
HUN has a Operating Margin of 0.87%. This is in the lower half of the industry: HUN underperforms 79.52% of its industry peers.
HUN's Operating Margin has declined in the last couple of years.
HUN has a Gross Margin of 13.74%. This is in the lower half of the industry: HUN underperforms 75.90% of its industry peers.
In the last couple of years the Gross Margin of HUN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.87% | ||
| PM (TTM) | N/A | ||
| GM | 13.74% |
OM growth 3Y-50.02%
OM growth 5Y-28.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.43%
GM growth 5Y-6.74%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HUN is destroying value.
Compared to 1 year ago, HUN has more shares outstanding
Compared to 5 years ago, HUN has less shares outstanding
HUN has a worse debt/assets ratio than last year.
2.2 Solvency
HUN has an Altman-Z score of 1.54. This is a bad value and indicates that HUN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of HUN (1.54) is worse than 65.06% of its industry peers.
HUN has a debt to FCF ratio of 15.19. This is a negative value and a sign of low solvency as HUN would need 15.19 years to pay back of all of its debts.
HUN's Debt to FCF ratio of 15.19 is in line compared to the rest of the industry. HUN outperforms 53.01% of its industry peers.
HUN has a Debt/Equity ratio of 0.59. This is a neutral value indicating HUN is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.59, HUN is doing good in the industry, outperforming 61.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 15.19 | ||
| Altman-Z | 1.54 |
ROIC/WACC0.09
WACC7.6%
2.3 Liquidity
HUN has a Current Ratio of 1.43. This is a normal value and indicates that HUN is financially healthy and should not expect problems in meeting its short term obligations.
HUN has a worse Current ratio (1.43) than 74.70% of its industry peers.
A Quick Ratio of 0.85 indicates that HUN may have some problems paying its short term obligations.
HUN has a Quick ratio of 0.85. This is in the lower half of the industry: HUN underperforms 77.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
HUN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2400.00%.
Looking at the last year, HUN shows a decrease in Revenue. The Revenue has decreased by -1.56% in the last year.
HUN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.35% yearly.
EPS 1Y (TTM)-2400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-242.86%
Revenue 1Y (TTM)-1.56%
Revenue growth 3Y-7.68%
Revenue growth 5Y-2.35%
Sales Q2Q%-7.37%
3.2 Future
HUN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 108.55% yearly.
Based on estimates for the next years, HUN will show a small growth in Revenue. The Revenue will grow by 1.22% on average per year.
EPS Next Y-859.95%
EPS Next 2Y-9.06%
EPS Next 3Y108.55%
EPS Next 5YN/A
Revenue Next Year-4.39%
Revenue Next 2Y-0.05%
Revenue Next 3Y1.22%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
HUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HUN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
62.65% of the companies in the same industry are more expensive than HUN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, HUN is valued cheaper than 86.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.35 | ||
| EV/EBITDA | 9.06 |
4.3 Compensation for Growth
HUN's earnings are expected to grow with 108.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.06%
EPS Next 3Y108.55%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 11.90%, HUN is a good candidate for dividend investing.
The stock price of HUN dropped by -21.81% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
HUN's Dividend Yield is rather good when compared to the industry average which is at 3.76. HUN pays more dividend than 98.80% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, HUN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.9% |
5.2 History
On average, the dividend of HUN grows each year by 9.05%, which is quite nice.
HUN has been paying a dividend for at least 10 years, so it has a reliable track record.
HUN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)9.05%
Div Incr Years4
Div Non Decr Years17
5.3 Sustainability
The earnings of HUN are negative and hence is the payout ratio. HUN will probably not be able to sustain this dividend level.
HUN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-51.63%
EPS Next 2Y-9.06%
EPS Next 3Y108.55%
8.75
+0.59 (+7.23%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners93%
Inst Owner Change-0.71%
Ins Owners5.31%
Ins Owner Change0.85%
Market Cap1.52B
Revenue(TTM)5.86B
Net Income(TTM)-337000000
Analysts55
Price Target10.75 (22.86%)
Short Float %9.07%
Short Ratio3
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.9% |
Yearly Dividend1.01
Dividend Growth(5Y)9.05%
DP-51.63%
Div Incr Years4
Div Non Decr Years17
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.68%
Min EPS beat(2)-64.52%
Max EPS beat(2)-0.84%
EPS beat(4)1
Avg EPS beat(4)-53.28%
Min EPS beat(4)-152.09%
Max EPS beat(4)4.35%
EPS beat(8)1
Avg EPS beat(8)-32.62%
EPS beat(12)2
Avg EPS beat(12)-27.18%
EPS beat(16)6
Avg EPS beat(16)-17.7%
Revenue beat(2)0
Avg Revenue beat(2)-4.85%
Min Revenue beat(2)-6.25%
Max Revenue beat(2)-3.44%
Revenue beat(4)0
Avg Revenue beat(4)-2.94%
Min Revenue beat(4)-6.25%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.96%
Revenue beat(12)2
Avg Revenue beat(12)-2.01%
Revenue beat(16)3
Avg Revenue beat(16)-2.37%
PT rev (1m)0%
PT rev (3m)-18.69%
EPS NQ rev (1m)-0.79%
EPS NQ rev (3m)-367.35%
EPS NY rev (1m)-3.9%
EPS NY rev (3m)-70.87%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)-5.15%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-2.71%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.26 | ||
| P/FCF | 11.35 | ||
| P/OCF | 5.08 | ||
| P/B | 0.54 | ||
| P/tB | 0.83 | ||
| EV/EBITDA | 9.06 |
EPS(TTM)-0.46
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.77
FCFY8.81%
OCF(TTM)1.72
OCFY19.67%
SpS33.73
BVpS16.12
TBVpS10.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.72% | ||
| ROE | -12.03% | ||
| ROCE | 0.91% | ||
| ROIC | 0.72% | ||
| ROICexc | 0.77% | ||
| ROICexgc | 0.95% | ||
| OM | 0.87% | ||
| PM (TTM) | N/A | ||
| GM | 13.74% | ||
| FCFM | 2.29% |
ROA(3y)1.44%
ROA(5y)5.47%
ROE(3y)3.16%
ROE(5y)12.59%
ROIC(3y)3.85%
ROIC(5y)4.46%
ROICexc(3y)4.26%
ROICexc(5y)5.51%
ROICexgc(3y)5.21%
ROICexgc(5y)6.86%
ROCE(3y)4.87%
ROCE(5y)5.65%
ROICexgc growth 3Y-54.19%
ROICexgc growth 5Y-26.52%
ROICexc growth 3Y-53.71%
ROICexc growth 5Y-28.3%
OM growth 3Y-50.02%
OM growth 5Y-28.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.43%
GM growth 5Y-6.74%
F-Score5
Asset Turnover0.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 15.19 | ||
| Debt/EBITDA | 4.93 | ||
| Cap/Depr | 57.69% | ||
| Cap/Sales | 2.82% | ||
| Interest Coverage | 0.64 | ||
| Cash Conversion | 88.72% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | 1.54 |
F-Score5
WACC7.6%
ROIC/WACC0.09
Cap/Depr(3y)81.07%
Cap/Depr(5y)89.35%
Cap/Sales(3y)3.4%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-242.86%
EPS Next Y-859.95%
EPS Next 2Y-9.06%
EPS Next 3Y108.55%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.56%
Revenue growth 3Y-7.68%
Revenue growth 5Y-2.35%
Sales Q2Q%-7.37%
Revenue Next Year-4.39%
Revenue Next 2Y-0.05%
Revenue Next 3Y1.22%
Revenue Next 5YN/A
EBIT growth 1Y142.86%
EBIT growth 3Y-53.86%
EBIT growth 5Y-29.79%
EBIT Next Year112.18%
EBIT Next 3Y57.81%
EBIT Next 5YN/A
FCF growth 1Y-46.18%
FCF growth 3Y-49.41%
FCF growth 5Y-33.84%
OCF growth 1Y-37.71%
OCF growth 3Y-34.87%
OCF growth 5Y-21.76%